News - Radboudumc

News items related to the Department of Clinical Pharmacy.

Dosing anticancer drugs in patients with renal or hepatic impairment

11 April 2019

Renal or hepatic impairment is a common comorbidity for patients with cancer either because of the disease itself, toxicity of previous anticancer treatments, or because of other factors affecting organ function, such as increased age.

Importance of prospective studies in pregnant and breastfeeding women living with HIV

14 March 2019

In Clinical Infectious Diseases Angela Colbers, Stein Schalkwijk and David Burger give considerations on how to effectively evaluate aspects of clinical pharmacology required for safe and effective treatment to optimize pharmacotherapy during pregnancy and breastfeeding.

Beyond the scientist: Roger Brüggemann

13 November 2018

Roger, who subscribed for the national pilot academy in 1992, eventually became a hospital pharmacist and associate professor of clinical pharmacology. This summer he became a “Cinglé du Ventoux”.

Pharmacy receives prestigious European prize for research in Africa

27 September 2018

On 17 September, David Burger, professor of clinical pharmacy, together with colleagues from the United Kingdom, Uganda and Zimbabwe, received the "Outstanding Research Team" award from the European - Developing Countries Clinical Trial Partnership (EDCTP).

Nielka van Erp and Roger Brüggemann appointed associate professor

30 August 2018

It is our pleasure to announce that Nielka van Erp and Roger Brüggemann have been appointed as associated professor.

WHO Toolkit Pregnant and breastfeeding women

8 August 2018

Stein Schalkwijk, Angela Colbers and David Burger (Pharmacy) developed the Toolkit in cooperation with Mark Mirochnick (Boston University) as a part of “Toolkit for research and development of paediatric antiretroviral drugs and formulations”.

The potential for shortening tuberculosis treatment with higher rifampicin doses

5 July 2018

In Clinical Infectious Diseases Elin Svensson and colleagues showed that increasing rifampicin exposure shortened the time needed to reach undetectable levels of bacteria in sputum.

Pharmacokinetics of HIV medicines in pregnant women

28 June 2018

In Clinical Pharmacokinetics David Burger, Ruben van der Galiën and colleagues discuss that although yearly over a million of women with HIV get pregnant, it is often still unknown whether treatment with HIV-integrase inhibitors results in adequate drug exposure.

Reduced-dose efavirenz in HIV-positive pregnant women

14 March 2018

In Clinical Pharmacokinetics Stein Schalkwijk and colleagues described the feasibility to reduce the efavirenz dose in HIV-positive pregnant women to minimize treatment costs and limit toxicity.

Martijn Verbrugge Award for Pauline Bollen

6 February 2018

Pauline received this award for the best abstract of original research on HIV-infected patients. Lecture title: The pharmacokinetics and safety of dolutegravir in HIV-infected pregnant women.

Beyond the scientist: Roeland Wasmann

7 December 2017

Chair of the RIHS PhD council and PhD candidate at the department of Pharmacy, with focus on Pharmacokinetics of antifungals in morbidly obese adults.

Kees Kramers appointed Professor of Medication safety